David LinetskyPoint-of-Care Marketing
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Matt TurnerPatient Affordability
Paul TheisenPatient Acquisition
Suma Ramadas, PhDMedical Affairs
Daniel SontupeMarket Access
Joey CohenMedication Adherence
Bud BilanichSuccess Coach
Brenda SnowAuthentic Patient Voice
Matthew DurhamOmnidynamic Marketing
Liz KaneImpactful Strategy
Frank BurrellScientific Storytelling
Pat PurcellMeeting Engagement
Xolair® (omalizumab), indicated as add-on therapy for the treatment of chronic spontaneous urticaria (CSU)[1], ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email